vimarsana.com

Latest Breaking News On - Adam gridley - Page 1 : vimarsana.com

Allay Therapeutics Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief

Allay Therapeutics Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutica

SAN JOSE, Calif. & OSAKA, Japan (BUSINESS WIRE) Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with Maruishi Pharmaceutical Co., Ltd. (Maruishi), providing Maruishi with exclusive rights to develop and commercialize Allay’s lead investigational drug candidate, ATX1.

vimarsana © 2020. All Rights Reserved.